Berenberg initiated coverage of Medacta Group with a Buy rating and CHF 150 price target. The firm’s channel checks with surgeons and industry executives have given it confidence that the business can continue to grow well ahead of the broader market in the medium term.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on MEDGF:
- Medacta Group price target raised to CHF 125 from CHF 113 at Morgan Stanley
- Medacta Group upgraded to Buy from Neutral at UBS
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue